Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Gsk (GLAXF) Return on Invested Capital (2016 - 2023)

Historic Return on Invested Capital for Gsk (GLAXF) over the last 11 years, with Q4 2023 value amounting to 0.38%.

  • Gsk's Return on Invested Capital changed N/A to 0.38% in Q4 2023 from the same period last year, while for Dec 2023 it was 0.38%, marking a year-over-year change of. This contributed to the annual value of 0.07% for FY2024, which is 800.0% down from last year.
  • According to the latest figures from Q4 2023, Gsk's Return on Invested Capital is 0.38%.
  • Gsk's Return on Invested Capital's 5-year high stood at 4.65% during Q3 2019, with a 5-year trough of 0.38% in Q4 2023.
  • Over the past 3 years, Gsk's median Return on Invested Capital value was 0.81% (recorded in 2019), while the average stood at 1.71%.
  • Within the past 5 years, the most significant YoY rise in Gsk's Return on Invested Capital was 14800bps (2019), while the steepest drop was -2200bps (2019).
  • Over the past 3 years, Gsk's Return on Invested Capital (Quarter) stood at 0.73% in 2019, then rose by 20bps to 0.88% in 2021, then plummeted by -57bps to 0.38% in 2023.
  • Its Return on Invested Capital stands at 0.38% for Q4 2023, versus 0.88% for Q1 2021 and 0.73% for Q4 2019.